Department of Surgery, University of Vermont College of Medicine, Burlington, Vermont 05401, USA.
J Surg Res. 2010 Nov;164(1):84-90. doi: 10.1016/j.jss.2009.03.068. Epub 2009 May 3.
The purpose of this study is to examine the use of daikenchuto (DKT), a traditional Japanese medicine, as a potential treatment for opiate-induced slowing of intestinal transit in an isolated guinea pig colon model of motility.
Isolated segments of distal guinea pig colon were mounted in a perfusion chamber and imaged with a digital video camera interfaced with a computer. Fecal pellets were inserted into the oral end of the colonic segment and the rates of propulsive motility over a 3 to 4 cm segment of colon were determined in the presence and absence of test compounds. In addition, intracellular recordings were obtained from intact circular muscle, and the responsiveness of inhibitory and excitatory junction potentials to DKT was evaluated.
The addition of D-Ala2, N-Me-Phe4, Gly-ol5 (DAMGO), a selective μ-receptor agonist, caused a concentration dependent decrease in colon motility. Naloxone did not affect basal activity, but partially restored motility in the DAMGO treated preparations. DKT (1 × 10(-4)-3 × 10(-4)g/mL) also reversed the inhibitory effect of DAMGO treated colon in a concentration dependent manner. At higher concentrations (1 × 10(-3)-3 × 10(-3)g/mL), however, this effect was lost. Motility slowed even further when naloxone and DKT were combined with noticeable disruptions in spatiotemporal patterns. Interestingly, when added alone, DKT resulted in reverse peristalsis of the pellet. In electrophysiologic studies DKT inhibited both excitatory and inhibitory junction potentials.
DKT appears to be as effective as naloxone in restoring motility in DAMGO treated colon. These two agents, however, do not appear to have an additive effect. When used on untreated colon segments, DKT appears to cause disruptions in the intrinsic reflex circuit of the gut resulting in a disruption of neuromuscular communication.
本研究旨在探讨大建中汤(DKT)作为一种潜在的治疗药物,在运动性孤立豚鼠结肠模型中治疗阿片类药物引起的肠道转运减慢的作用。
将远端豚鼠结肠段置于灌注室中,并用与计算机接口的数字摄像机进行成像。将粪便颗粒插入结肠段的口腔端,在存在和不存在测试化合物的情况下,确定 3 到 4 厘米结肠段的推进运动速度。此外,还从完整的环形肌肉中获得细胞内记录,并评估 DKT 对抑制性和兴奋性突触后电位的反应。
添加 D-Ala2、N-Me-Phe4、Gly-ol5(DAMGO),一种选择性μ-受体激动剂,导致结肠运动呈浓度依赖性下降。纳洛酮不影响基础活性,但部分恢复 DAMGO 处理制剂的运动。DKT(1×10(-4)-3×10(-4)g/mL)也以浓度依赖性方式逆转 DAMGO 处理结肠的抑制作用。然而,在较高浓度(1×10(-3)-3×10(-3)g/mL)下,这种作用消失。当纳洛酮和 DKT 与空间和时间模式的明显中断一起使用时,运动速度甚至进一步减慢。有趣的是,当单独添加时,DKT 导致颗粒的逆行蠕动。在电生理研究中,DKT 抑制了兴奋性和抑制性突触后电位。
DKT 似乎与纳洛酮一样有效,可恢复 DAMGO 处理结肠的运动。然而,这两种药物似乎没有相加作用。当用于未处理的结肠段时,DKT 似乎会导致肠道内在反射回路的中断,从而导致神经肌肉通讯中断。